Skip to content

AtriCure ATRC Net Change in Cash

Net Change in Cash at other companies

Abbott logo
AbbottABT
-$1.72B-58.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Boston Scientific logo
Boston ScientificBSX
-$504M-261%
Medtronic logo
MedtronicMDT
-$136M+11.7%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
-$12.42M-1,100%
ITG
Integer HoldingsITGR
-$9.05M+39.0%

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
Enterprise value$1.36B-13.1%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's net change in cash?
AtriCure (ATRC) reported net change in cash of -$21.26M in Q1 2026.
How has AtriCure's net change in cash changed year-over-year?
AtriCure's net change in cash increased by 6.9% year-over-year, from -$22.84M to -$21.26M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.